Navigation Links
Cytokinetics Reports Additional Clinical Trials Data for Ispinesib

t is being prepared.

?These three Phase II clinical trials sponsored by NCI are components of a clinical trials program designed to identify signals of clinical activity of ispinesib across multiple tumor types,? stated Dr. Andrew A. Wolff, Cytokinetics Senior Vice President of Clinical Research and Development and Chief Medical Officer. ?Although these three trials did not meet the protocol-specified criteria for progression, we are encouraged by the anti-cancer activity of ispinesib observed to date in three other Phase II trials in breast, ovarian and non-small cell lung cancers. Based on these data, we plan to move forward in further clinical development of ispinesib with a focused approach to the potential treatment of breast cancer with ispinesib.?

Clinical Trials of Ispinesib

Ispinesib has been the subject of a broad Phase II clinical trials program under the sponsorship of GlaxoSmithKline (GSK) and is also being developed in collaboration with the NCI. GSK has sponsored three Phase II clinical trials, one evaluating ispinesib as second- or third-line treatment for patients with locally advanced or metastatic breast cancer, one evaluating ispinesib as second-line treatment for patients with non-small cell lung cancer, and one evaluating ispinesib as second-line treatment for patients with advanced ovarian cancer. Enrollment in all of these trials has been closed. To date, clinical activity with ispinesib has been observed in breast cancer, in non-small cell lung cancer, and ovarian cancer with the more robust clinical activity observed in a Phase II clinical trial evaluating ispinesib in the treatment of metastatic breast cancer patients that have failed treatment with taxanes and anthracyclines. In this clinical trial, The best overall responses observed with ispinesib were partial responses in 4 of 45 evaluable patients as measured by the RECIST criteria. Responses were confirmed by independent radiology review and were seen in
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cytokinetics Announces Non-clinical Data to be Presented at the 2007 AACR Annual Meeting
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:11/26/2014)... 25, 2014  goBalto, Inc., the leading provider of ... a winner of Red Herring,s Top 100 Global ... North America award in 2013, marking its emergence as ... Red Herring,s Top 100 Global list has become ... and entrepreneurs. Red Herring editors were among the first ...
(Date:11/26/2014)... , Nov. 25, 2014  Unilife Corporation (NASDAQ: UNIS, ... drug delivery systems, today announced that its Chairman and ... at the Piper Jaffray 26th Annual Healthcare Conference at ... on Tuesday, December 2, 2014. The ... a "live" listen only Webcast. To listen, please go ...
(Date:11/26/2014)... HERZLIYA PITUACH, Israel, Nov. 25, 2014 Immune ... a clinical stage biopharmaceutical company that engages in ... the treatment of inflammatory diseases and cancer, today ... public offering of 3,450,000 units, with each unit ... stock, par value $0.0001 per share, and one ...
Breaking Medicine Technology:goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 2Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 3Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 4Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 5
... Aug. 8, 2011 Endologix, Inc. (Nasdaq: ... for aortic disorders, announced today that the first U.S. ... was performed at Edward Hines, Jr. VA Hospital in ... M.D., F.A.C.S., Associate Professor and Chief of Vascular Surgery ...
... leading manufacturer of integrated medical imaging display and communication systems, ... Medical achieved significant growth in sales and an expansion of ... with record second quarter sales, Carrot surpassed its revenue mark ... now well positioned for the third straight year of triple ...
Cached Medicine Technology:Endologix Announces First U.S. Implant of AFX™ Endovascular AAA System 2Carrot Medical Positioned for Third Straight Year of Triple Digit Growth 2
(Date:11/26/2014)... Rosa, California (PRWEB) November 26, 2014 ... making never before seen reductions in prices of their ... and Liposomal Vitamin D3 . Discounts of ... , GI for Life’s proprietary ColoVite supplement ... board-certified gastroenterologists to promote colon health. One easy-to-take colon ...
(Date:11/26/2014)... 2014 Anthropologists have identified concrete ... and stopping Ebola, improve international support, and pave ... in West Africa. , The report, “Strengthening ... Anthropologists Offer Insights,” will be made public during ... Association (AAA), Fri., Dec. 5, 11 a.m., at ...
(Date:11/26/2014)... 2014 For those with a New Year’s ... MILLS BODYPUMP™ classes at the University of Colorado Anschutz ... been looking for. The 45- 60 minute classes have just ... Wellness Center fitness club memberships. , LES MILLS BODYPUMP™ exercise ... and are aimed at fast results , By focusing ...
(Date:11/26/2014)... of the most important and vital decisions a woman ... choosing the ideal wedding dress and bridesmaid dresses. BellasDress.com ... quality outfits. Today, BellasDress.com has unveiled its new range ... suitable bridesmaid gowns here at discount prices. , Formal ... and highlight all their most beautiful features while drawing ...
(Date:11/26/2014)... of emergency department visits in the United States rose from ... in 2011, according to the U.S. Centers for Disease Control ... were going to ERs with non-urgent medical needs: 96 percent ... hours of arriving at the ER. In 2010, that number ... of patients arrived at the ER after normal business hours ...
Breaking Medicine News(10 mins):Health News:GI For Life Slashes Prices by 40% on Liposomal Vitamin D3 and ColoVite Colon Health Formula for a Limited Time 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 3Health News:LES MILLS BODYPUMP™ classes come to the University of Colorado Anschutz Health and Wellness Center 2Health News:Royal Blue Bridesmaid Dresses Now Are Available for Christmas at BellasDress.com 2Health News:ER Visits on the Rise, Study Reports 2
... , FORT COLLINS, Colo., Nov. 17 ... and educator Alan D. Wolfelt, Ph.D. has been released in time ... Understanding Your Suicide Grief: Ten Essential Touchstones for Finding ... when someone we love takes their life, and describes ten benchmarks ...
... believed that, following a stroke, a patient had about ... patients would be forced to compensate for the lost ... belief has been refuted, a University of Missouri occupational ... still not giving patients enough time to recover and ...
... ... training provided by the eMedia eMPowerment Series from Web Campus World Wide , ... WWW & Spanish Fork, ... Michael P. Eyre, and Dr. Chad R. Peterson interested in extending their client service ...
... , NEW YORK, Nov. 17 As we approach Thanksgiving, ... (NYBC) calls upon the community to please remember the children ... frequent blood transfusions for recovery and survival. Among these ... aplastic anemias, sickle cell disease, hemophilia and other diseases. , ...
... , SAN CLEMENTE, Calif., Nov. 17 Calcium is ... or - especially - if you,re pregnant. Unfortunately, with most ... leaves them, and often times their growing fetus, starved for calcium. ... March of Dimes (nacersano.org), an organization committed to moms and baby,s ...
... , , LAS VEGAS, Nov. 17 Ultimat Vodka ... international organization committed to eliminating world hunger, to help raise ... with an organization called "I,m Tired of...," (ITo) Ultimat ... metals, that carry the message "I,m Tired of Hunger." For ...
Cached Medicine News:Health News:Release of 'Understanding Your Suicide Grief' by Dr. Alan Wolfelt 2Health News:Release of 'Understanding Your Suicide Grief' by Dr. Alan Wolfelt 3Health News:Release of 'Understanding Your Suicide Grief' by Dr. Alan Wolfelt 4Health News:Release of 'Understanding Your Suicide Grief' by Dr. Alan Wolfelt 5Health News:Pushing the brain to find new pathways 2Health News:Aspen Dermatology Builds Client Communication with Training by Web Campus World Wide 2Health News:Aspen Dermatology Builds Client Communication with Training by Web Campus World Wide 3Health News:Aspen Dermatology Builds Client Communication with Training by Web Campus World Wide 4Health News:These Patients Need Your Help This Thanksgiving 2Health News:These Patients Need Your Help This Thanksgiving 3Health News:TOMA LECHE for Healthy, Strong Mom & Baby 2Health News:TOMA LECHE for Healthy, Strong Mom & Baby 3Health News:Ultimat Vodka Joins Fight Against Hunger 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: